Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × somapacitan × Endocrine × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Dwarfism, Pituitary 1 Diabetes Mellitus, Type 2 1

Interventions

somapacitan 1 irinotecan sucrosofate 1 PM 01183 1 Injections 1 Fluorodeoxyglucose F18 1 Diagnostic Self Evaluation 1 Carboplatin 1 Cabergoline 1 Bed Rest 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06709040 2025-02-05

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Novo Nordisk A/S

Enrolling by invitation

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡